Ibrutinib has some activity in Richter's syndrome.
作者信息
Giri S, Hahn A, Yaghmour G, Martin M G
机构信息
Department of Medicine, The University of Tennessee Health Science Center, Memphis, TN, USA.
Department of Hematology/Oncology, The West Clinic, Memphis, TN, USA.
出版信息
Blood Cancer J. 2015 Jan 30;5(1):e277. doi: 10.1038/bcj.2014.98.
Abstract
摘要
相似文献
1
Ibrutinib has some activity in Richter's syndrome.伊布替尼在里氏综合征中有一定活性。
Blood Cancer J. 2015 Jan 30;5(1):e277. doi: 10.1038/bcj.2014.98.
2
Ibrutinib-induced rapid response in chemotherapy-refractory Richter's syndrome.依鲁替尼在化疗难治性里氏综合征中引起快速反应。
Hematol Oncol. 2018 Feb;36(1):370-371. doi: 10.1002/hon.2464. Epub 2017 Jul 6.
3
Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.慢性髓性白血病与弥漫性大B细胞淋巴瘤并存并伴有既往慢性淋巴细胞白血病：一例报告及文献复习
J Med Case Rep. 2018 Mar 11;12(1):64. doi: 10.1186/s13256-018-1612-4.
4
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study.依鲁替尼联合纳武单抗治疗复发非霍奇金淋巴瘤或慢性淋巴细胞白血病患者的安全性和活性：一项1/2a期研究
Lancet Haematol. 2019 Feb;6(2):e67-e78. doi: 10.1016/S2352-3026(18)30217-5. Epub 2019 Jan 11.
5
Haematological cancer: Richter's transformation in CLL-a distinct lymphoma.血液系统恶性肿瘤：CLL 中的里希特转化——一种独特的淋巴瘤。
Nat Rev Clin Oncol. 2014 Jan;11(1):6-8. doi: 10.1038/nrclinonc.2013.229. Epub 2013 Nov 26.
6
EBV-positive Richter's syndrome with laboratory features of Burkitt's lymphoma, in Ibrutinib-treated chronic lymphocytic leukemia.接受依鲁替尼治疗的慢性淋巴细胞白血病中，伴有伯基特淋巴瘤实验室特征的EB病毒阳性里氏综合征
Leuk Lymphoma. 2017 Jul;58(7):1753-1756. doi: 10.1080/10428194.2016.1256482. Epub 2016 Nov 16.
7
Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia.伊布替尼治疗慢性淋巴细胞白血病期间发生的非典型原发性皮肤隐球菌病。
Ann Hematol. 2019 Dec;98(12):2847-2849. doi: 10.1007/s00277-019-03837-1. Epub 2019 Nov 18.
8
Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib.接受依鲁替尼治疗的慢性淋巴细胞白血病患者的季节性流感疫苗接种
JAMA Oncol. 2016 Dec 1;2(12):1656-1657. doi: 10.1001/jamaoncol.2016.2437.
9
Deciphering Ibrutinib Resistance in Chronic Lymphocytic Leukemia.解析慢性淋巴细胞白血病中依鲁替尼耐药性
J Clin Oncol. 2017 May 1;35(13):1451-1452. doi: 10.1200/JCO.2016.72.0102. Epub 2017 Mar 14.
10
Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia.17p缺失慢性淋巴细胞白血病患者的依鲁替尼皮疹
Am J Hematol. 2015 Feb;90(2):179. doi: 10.1002/ajh.23775. Epub 2014 Jun 20.
引用本文的文献
1
An experience with ibrutinib monotherapy for Richter's syndrome isolated in the central nervous system.中枢神经系统孤立性里希特综合征采用伊布替尼单药治疗的经验。
J Clin Exp Hematop. 2022 Dec 28;62(4):238-241. doi: 10.3960/jslrt.22017. Epub 2022 Nov 28.
2
Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia.B 细胞受体在慢性淋巴细胞白血病起源中的旧事实和新推测。
Int J Mol Sci. 2022 Nov 17;23(22):14249. doi: 10.3390/ijms232214249.
3
Richter Syndrome: From Molecular Pathogenesis to Druggable Targets.里氏综合征：从分子发病机制到可成药靶点
Cancers (Basel). 2022 Sep 24;14(19):4644. doi: 10.3390/cancers14194644.
4
Biology and Treatment of Richter Transformation.里氏转化的生物学特性与治疗
Front Oncol. 2022 Mar 22;12:829983. doi: 10.3389/fonc.2022.829983. eCollection 2022.
5
Novel Approaches for the Treatment of Patients with Richter's Syndrome.治疗里希特综合征患者的新方法。
Curr Treat Options Oncol. 2022 Apr;23(4):526-542. doi: 10.1007/s11864-022-00973-1. Epub 2022 Mar 16.
6
Late-chronic cardiotoxicity and heart failure caused by ibrutinib: a case report and literature review.依鲁替尼引起的迟发性慢性心脏毒性和心力衰竭：一例报告及文献综述
J Geriatr Cardiol. 2021 Apr 28;18(4):307-311. doi: 10.11909/j.issn.1671-5411.2021.04.009.
7
Richter Syndrome.里希特综合征。
Curr Oncol Rep. 2021 Feb 12;23(3):26. doi: 10.1007/s11912-020-01001-x.
8
Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病。
Cold Spring Harb Perspect Med. 2021 Feb 1;11(2):a035220. doi: 10.1101/cshperspect.a035220.
9
Current trends in the management of Richter's syndrome.里氏综合征管理的当前趋势。
Int J Hematol Oncol. 2019 Jan 8;7(4):IJH09. doi: 10.2217/ijh-2018-0010. eCollection 2018 Dec.
10
Two distinct histological Richter's transformations 23 years apart in a patient with chronic lymphocytic leukaemia.一名慢性淋巴细胞白血病患者在相隔23年的时间里发生了两种不同组织学类型的 Richter 转化。
BMJ Case Rep. 2018 Oct 8;2018:bcr-2018-225893. doi: 10.1136/bcr-2018-225893.
本文引用的文献
1
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.伊布替尼与奥法妥木单抗治疗既往治疗的慢性淋巴细胞白血病。
N Engl J Med. 2014 Jul 17;371(3):213-23. doi: 10.1056/NEJMoa1400376. Epub 2014 May 31.
2
How we treat Richter syndrome.我们如何治疗里希特综合征。
Blood. 2014 Mar 13;123(11):1647-57. doi: 10.1182/blood-2013-11-516229. Epub 2014 Jan 13.
3
Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome.奥沙利铂、氟达拉滨、阿糖胞苷和利妥昔单抗联合治疗侵袭性复发/难治性慢性淋巴细胞白血病或里希特综合征的 I- II 期临床试验。
Clin Lymphoma Myeloma Leuk. 2013 Oct;13(5):568-74. doi: 10.1016/j.clml.2013.03.012. Epub 2013 Jun 27.
4
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.伊布替尼治疗复发慢性淋巴细胞白血病的 BTK 靶点。
N Engl J Med. 2013 Jul 4;369(1):32-42. doi: 10.1056/NEJMoa1215637. Epub 2013 Jun 19.
5
Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.奥沙利铂、氟达拉滨、阿糖胞苷和利妥昔单抗联合治疗 Richter 综合征或氟达拉滨难治性慢性淋巴细胞白血病患者的 I-II 期研究
J Clin Oncol. 2008 Jan 10;26(2):196-203. doi: 10.1200/JCO.2007.11.8513.
6
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia.对于Richter综合征或氟达拉滨难治性慢性淋巴细胞白血病患者，采用环磷酰胺、长春新碱、脂质体柔红霉素、地塞米松联合利妥昔单抗及粒细胞巨噬细胞集落刺激因子（GM-CSF），与甲氨蝶呤、阿糖胞苷联合利妥昔单抗及GM-CSF交替使用。
Cancer. 2003 Apr 1;97(7):1711-20. doi: 10.1002/cncr.11238.
7
Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders.氟达拉滨、阿糖胞苷（Ara-C）、环磷酰胺、顺铂和粒细胞巨噬细胞集落刺激因子（FACPGM）治疗里氏综合征或难治性淋巴增殖性疾病患者的II期研究。
Leuk Lymphoma. 2002 Apr;43(4):767-72. doi: 10.1080/10428190290016872.
8
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome.环磷酰胺、长春新碱、脂质体柔红霉素（柔红霉素脂质体）和地塞米松（hyperCVXD）方案治疗里氏综合征
Leuk Lymphoma. 2001 Jul;42(3):329-37. doi: 10.3109/10428190109064589.
Zotero 插件